{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:00:39Z","timestamp":1781701239825,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113\\u20132311-B-182\\u2013004-MY3"],"award-info":[{"award-number":["NSTC 113\\u20132311-B-182\\u2013004-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2025.117603","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:49:05Z","timestamp":1764834545000},"page":"117603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combination of two Na+ channel-inhibiting anticonvulsants lacosamide and phenytoin: An additive, synergistic, or antagonistic effect?"],"prefix":"10.1016","volume":"245","author":[{"given":"Tien-Hung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9983-0607","authenticated-orcid":false,"given":"Ya-Chin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2025.117603_b0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eplepsyres.2007.11.011","article-title":"Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy","volume":"78","author":"Aroniadou-Anderjaska","year":"2008","journal-title":"Epilepsy Res."},{"issue":"7","key":"10.1016\/j.bcp.2025.117603_b0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.bbamem.2012.07.028","article-title":"T-type calcium channels in burst-firing, network synchrony, and epilepsy","volume":"1828","author":"Cain","year":"2013","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0920-1211(87)90047-7","article-title":"Structurally stable burst and synchronized firing in human amygdala neurons: Auto- and cross-correlation analyses in temporal lobe epilepsy","volume":"1","author":"Isokawa-Akesson","year":"1987","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1113\/jphysiol.2012.239590","article-title":"Synchronization and desynchronization in epilepsy: Controversies and hypotheses","volume":"591","author":"Jiruska","year":"2013","journal-title":"J. Physiol."},{"issue":"36","key":"10.1016\/j.bcp.2025.117603_b0195","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1523\/JNEUROSCI.0669-21.2021","article-title":"Connectivity and neuronal synchrony during seizures","volume":"41","author":"Ren","year":"2021","journal-title":"J. Neurosci."},{"issue":"4547","key":"10.1016\/j.bcp.2025.117603_b0245","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.7079735","article-title":"Cellular mechanism of neuronal synchronization in epilepsy","volume":"216","author":"Traub","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117603_b0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.expneurol.2013.11.014","article-title":"Mechanism of highly synchronized bilateral hippocampal activity","volume":"251","author":"Wang","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0026-895X(24)26451-8","article-title":"Inhibition of na(+) current by diphenhydramine and other diphenyl compounds: Molecular determinants of selective binding to the inactivated channels","volume":"57","author":"Kuo","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117603_b0020","first-page":"441","article-title":"Molecular properties of brain sodium channels: an important target for anticonvulsant drugs","volume":"79","author":"Catterall","year":"1999","journal-title":"Adv. Neurol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0026-895X(24)13073-8","article-title":"A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels","volume":"54","author":"Kuo","year":"1998","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0110","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0026-895X(25)09804-9","article-title":"Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons","volume":"46","author":"Kuo","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117603_b0115","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1124\/mol.51.6.1077","article-title":"Carbamazepine inhibition of neuronal na+ currents: Quantitative distinction from phenytoin and possible therapeutic implications","volume":"51","author":"Kuo","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117603_b0125","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.bjp.0701221","article-title":"Characterization of lamotrigine inhibition of na+ channels in rat hippocampal neurones","volume":"121","author":"Kuo","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117603_b0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1085\/jgp.200810158","article-title":"The external pore loop interacts with s6 and s3-s4 linker in domain 4 to assume an essential role in gating control and anticonvulsant action in the na+ channel","volume":"134","author":"Yang","year":"2009","journal-title":"J. Gen. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0295","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ALN.0b013e3181dc1dd6","article-title":"Lidocaine, carbamazepine, and imipramine have partially overlapping binding sites and additive inhibitory effect on neuronal na+channels","volume":"113","author":"Yang","year":"2010","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.bcp.2025.117603_b0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","author":"Errington","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117603_b0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2014.09.008","article-title":"Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide","volume":"89","author":"Hebeisen","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13602","article-title":"Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow na+ channel inactivation","volume":"58","author":"Holtkamp","year":"2017","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.bcp.2025.117603_b0175","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jnr.23136","article-title":"Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation","volume":"91","author":"Niespodziany","year":"2013","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117603_b0210","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1021\/jm901563p","article-title":"Synthesis and anticonvulsant activities of (r)-n-(4\u2032-substituted)benzyl 2-acetamido-3-methoxypropionamides","volume":"53","author":"Salom\u00e9","year":"2010","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/jpet.107.133413","article-title":"Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2r)-2-(acetylamino)-n-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine","volume":"326","author":"Sheets","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0240","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1085\/jgp.201611668","article-title":"Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants","volume":"149","author":"Tikhonov","year":"2017","journal-title":"J. Gen. Physiol."},{"issue":"33","key":"10.1016\/j.bcp.2025.117603_b0265","doi-asserted-by":"crossref","first-page":"25296","DOI":"10.1074\/jbc.M110.128801","article-title":"In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117603_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108266","article-title":"Inhibition of neuronal Na+ currents by lacosamide: Differential binding affinity and kinetics to different inactivated states","volume":"179","author":"Peng","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/mol.116.106401","article-title":"Lacosamide inhibition of nav1.7 voltage-gated sodium channels: Slow binding to fast-inactivated states","volume":"91","author":"Jo","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117603_b0260","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/mol.113.091173","article-title":"Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway","volume":"85","author":"Wang","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0190","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0026-895X(25)09773-1","article-title":"Modification of slow inactivation of single sodium channels by phenytoin in neuroblastoma cells","volume":"34","author":"Quandt","year":"1988","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0305","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1152\/jn.01060.2015","article-title":"Effect of phenytoin on sodium conductances in rat hippocampal ca1 pyramidal neurons","volume":"116","author":"Zeng","year":"2016","journal-title":"J. Neurophysiol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117603_b0150","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s43440-020-00117-y","article-title":"Sub-additive (antagonistic) interaction of lacosamide with lamotrigine and valproate in the maximal electroshock-induced seizure model in mice: an isobolographic analysis","volume":"72","author":"\u0141uszczki","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2025.117603_b0220","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/epi.12237","article-title":"Synergism of lacosamide with established antiepileptic drugs in the 6-hz seizure model in mice","volume":"54","author":"Shandra","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2025.117603_b0300","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.3390\/ijms22115537","article-title":"Interactions among lacosamide and second-generation antiepileptic drugs in the tonic-clonic seizure model in mice","volume":"22(11)","author":"Za\u0142uska-Ogryzek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2025.117603_b0080","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1152\/japplphysiol.01585.2011","article-title":"Postnatal development and activation of L-type Ca2+ currents in locus ceruleus neurons: implications for a role for Ca2+ in central chemosensitivity","volume":"112","author":"Imber","year":"2012","journal-title":"J. Appl. Physiol."},{"issue":"22","key":"10.1016\/j.bcp.2025.117603_b0165","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1523\/JNEUROSCI.6136-09.2010","article-title":"Isolation of somatic Na+ currents by selective inactivation of axonal channels with a voltage prepulse","volume":"30","author":"Milescu","year":"2010","journal-title":"J. Neurosci."},{"issue":"36","key":"10.1016\/j.bcp.2025.117603_b0170","doi-asserted-by":"crossref","first-page":"12113","DOI":"10.1523\/JNEUROSCI.0445-10.2010","article-title":"Kinetic properties and functional dynamics of sodium channels during repetitive spiking in a slow pacemaker neuron","volume":"30","author":"Milescu","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055212","article-title":"A novel scn9a mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0010","first-page":"1","article-title":"Synergy, additivism and antagonism in immunosuppression - critical review","volume":"28","author":"Berenbaum","year":"1977","journal-title":"Clinical & Experimental Immunology"},{"key":"10.1016\/j.bcp.2025.117603_b0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117603_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"issue":"3","key":"10.1016\/j.bcp.2025.117603_b0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0959-4388(03)00065-5","article-title":"Mechanisms of sodium channel inactivation","volume":"13","author":"Goldin","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117603_b0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-642-41588-3_3","article-title":"Slow inactivation of Na(+) channels","volume":"221","author":"Silva","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0250","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1152\/physrev.00024.2004","article-title":"Sodium channel inactivation: molecular determinants and modulation","volume":"85","author":"Ulbricht","year":"2005","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2025.117603_b0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awaa016","article-title":"Differential effect of lacosamide on nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy","volume":"143","author":"Labau","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2025.117603_b0045","first-page":"347","article-title":"Sodium channels in normal and pathological pain","volume":"6","author":"Dib-Hajj","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bcp.2025.117603_b0025","doi-asserted-by":"crossref","unstructured":"Catterall, W. A. (2000). Structure and regulation of voltage-gated sodium channels. Annual Review of Cell and Developmental Biology, 16, 521\u2013555.","DOI":"10.1146\/annurev.cellbio.16.1.521"},{"key":"10.1016\/j.bcp.2025.117603_b0145","doi-asserted-by":"crossref","unstructured":"Lorincz, A., & Nusser, Z. (2010). Molecular identity of dendritic voltage-gated sodium channels. Science, 328(5980), 906\u2013909.","DOI":"10.1126\/science.1187958"},{"issue":"6","key":"10.1016\/j.bcp.2025.117603_b0135","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ana.26068","article-title":"How can an Na+channel inhibitor ameliorate seizures in Lennox-Gastaut syndrome?","volume":"89","author":"Lin","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2025.117603_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114928","article-title":"Selective stabilization of the intermediate inactivated Na+channel by the new-generation anticonvulsant rufinamide","volume":"197","author":"Lin","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"s2","key":"10.1016\/j.bcp.2025.117603_b0155","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1995.tb05996.x","article-title":"Antiepileptic drug mechanisms of action","volume":"36","author":"Macdonald","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2025.117603_b0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3565(25)21797-9","article-title":"Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells","volume":"228","author":"Matsuki","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117603_b0280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00373920","article-title":"Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA na_channels and with native na_channels in rat hippocampal neurons","volume":"430","author":"Xie","year":"1995","journal-title":"Pfle\u00fcgers Archiv European Journal of Physiology"},{"issue":"11","key":"10.1016\/j.bcp.2025.117603_b0030","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1177\/0091270011426875","article-title":"No pharmacokinetic interaction between lacosamide and valproic acid in healthy volunteers","volume":"52","author":"Cawello","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117603_b0235","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s11064-017-2234-8","article-title":"Therapeutic drug monitoring of lacosamide in norway: Focus on pharmacokinetic variability, efficacy and tolerability","volume":"42","author":"Svendsen","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bcp.2025.117603_b0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ebcr.2012.10.006","article-title":"Low-dose lacosamide-induced atrial fibrillation: case analysis with literature review","volume":"1","author":"Kaufman","year":"2013","journal-title":"Epilepsy & Behavior Case Reports"},{"issue":"10","key":"10.1016\/j.bcp.2025.117603_b0180","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1111\/j.1528-1167.2011.03212.x","article-title":"Lacosamide\u2010induced second\u2010degree atrioventricular block in a patient with partial epilepsy","volume":"52","author":"Nizam","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.bcp.2025.117603_b0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/ane.12414","article-title":"Lacosamide cardiac safety: clinical trials in patients with partial\u2010onset seizures","volume":"132","author":"Rudd","year":"2015","journal-title":"Acta Neurol. Scand."},{"issue":"12","key":"10.1016\/j.bcp.2025.117603_b0285","article-title":"Lacosamide-related arrhythmias: a systematic analysis and review of the literature","volume":"13","author":"Yadav","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.bcp.2025.117603_b0060","article-title":"A Clinical-EEG Study of Sleepiness and Psychological Symptoms in Pharmacoresistant Epilepsy patients Treated with Lacosamide","volume":"2013","author":"Giorgi","year":"2013","journal-title":"Epilepsy Research and Treatment"},{"key":"10.1016\/j.bcp.2025.117603_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2023.06.022","article-title":"Effect of Lacosamide on Interictal Epileptiform Discharges in Pediatric patients with newly Diagnosed Focal Epilepsy","volume":"147","author":"Hoshino","year":"2023","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117603_b0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pediatrneurol.2005.03.001","article-title":"Aggravation of epilepsy by antiepileptic drugs","volume":"33","author":"Sazgar","year":"2005","journal-title":"Pediatr. Neurol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:12:47Z","timestamp":1781698367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"alternative-id":["S0006295225008688"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117603","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of two Na+ channel-inhibiting anticonvulsants lacosamide and phenytoin: An additive, synergistic, or antagonistic effect?","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117603"}}